1. Home
  2. ADCT vs NATR Comparison

ADCT vs NATR Comparison

Compare ADCT & NATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ADC Therapeutics SA

ADCT

ADC Therapeutics SA

HOLD

Current Price

$3.13

Market Cap

445.2M

Sector

Health Care

ML Signal

HOLD

Logo Nature's Sunshine Products Inc.

NATR

Nature's Sunshine Products Inc.

HOLD

Current Price

$21.87

Market Cap

392.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADCT
NATR
Founded
2011
1972
Country
Switzerland
United States
Employees
N/A
806
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
445.2M
392.7M
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
ADCT
NATR
Price
$3.13
$21.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$7.75
$28.33
AVG Volume (30 Days)
1.1M
71.3K
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
30.86
165.00
EPS
N/A
0.29
Revenue
$81,357,000.00
$480,144,000.00
Revenue This Year
N/A
$7.76
Revenue Next Year
$66.49
$4.82
P/E Ratio
N/A
$76.79
Revenue Growth
14.85
5.67
52 Week Low
$1.83
$12.97
52 Week High
$4.98
$28.14

Technical Indicators

Market Signals
Indicator
ADCT
NATR
Relative Strength Index (RSI) 27.42 24.82
Support Level $3.11 $21.27
Resistance Level $4.73 $27.74
Average True Range (ATR) 0.22 1.27
MACD -0.06 -0.43
Stochastic Oscillator 3.40 9.25

Price Performance

Historical Comparison
ADCT
NATR

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. Additionally, the company's development pipeline comprises LOTIS-2, LOTIS-5, LOTIS-7, and ADCT-241, being developed as potential therapies for different cancer diseases. Geographically, the firm generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

About NATR Nature's Sunshine Products Inc.

Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products. The following Companies' product lines include: General health: Assorted health products related to blood sugar, bone health, cellular health, etc. Immune: offer products that support and strengthen the human immune system, Cardiovascular: Ingredients to give the cardiovascular system optimum support. Digestive: regulates intestinal and digestive functions, Personal care: personal care products for external use, and Weight management: to simplify the weight management process by providing healthy meal replacements. Business segment: Asia, Europe, North America, Latin America, and Other. The majority of revenue is from Asia.

Share on Social Networks: